Phibro Animal Health (PAHC) Net Cash Flow Growth (1y) (2014 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 73.93% |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | -167.84% |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 272.00% |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | -6.86% |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -296.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.86% |
| Mar 31, 2026 | 60.38% |
| Dec 31, 2025 | -188.84% |
| Sep 30, 2025 | 123.70% |
| Jun 30, 2025 | -69.33% |
| Mar 31, 2025 | -142.09% |
| Dec 31, 2024 | 336.30% |
| Sep 30, 2024 | -1,010.17% |
| Jun 30, 2024 | 482.37% |
| Mar 31, 2024 | 155.68% |
| Dec 31, 2023 | 6.70% |
| Sep 30, 2023 | -13.31% |
| Jun 30, 2023 | -18.06% |
| Mar 31, 2023 | -584.02% |
| Dec 31, 2022 | -137.13% |
| Sep 30, 2022 | 128.81% |
| Jun 30, 2022 | 755.51% |
| Mar 31, 2022 | -56.82% |
| Dec 31, 2021 | 741.43% |
| Sep 30, 2021 | -56.60% |